Home/Filings/4/0001415889-25-004222
4//SEC Filing

van der Horst Edward 4

Accession 0001415889-25-004222

CIK 0001829802other

Filed

Feb 13, 7:00 PM ET

Accepted

Feb 14, 6:01 PM ET

Size

5.7 KB

Accession

0001415889-25-004222

Insider Transaction Report

Form 4
Period: 2025-02-14
van der Horst Edward
CHIEF SCIENTIFIC OFFICER
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-02-14+110,000110,000 total
    Exercise: $0.48Exp: 2035-02-13Common Stock (110,000 underlying)
Footnotes (1)
  • [F1]The option shall vest over a period of four years as follows: 25% of the total number of shares subject to the option shall vest on February 14, 2026, and the remainder will vest 1/48th of total number of shares subject to the option monthly thereafter over the remaining three years, subject to the Reporting Person's continuous service with the Issuer as of each such date.

Issuer

Sensei Biotherapeutics, Inc.

CIK 0001829802

Entity typeother

Related Parties

1
  • filerCIK 0001957499

Filing Metadata

Form type
4
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 6:01 PM ET
Size
5.7 KB